Engineering Protein Stability in Dissolving Microneedle Patches: Mechanistic Principles, Polymer Engineering, Formulation Strategies, and Clinical Translation for Insulin and Other Biologics
Open Access
- 15 October 2026
- journal article
- review article
- Published by MDPI AG in Journal of Pharmaceutical and BioTech Industry
- Vol. 3 (4) , 25
Abstract
Protein therapeutics such as insulin, monoclonal antibodies, peptide hormones, cytokines, enzymes and vaccine antigens have revolutionized the treatment of chronic and complex diseases, but are currently constrained by adherence issues with frequent injection, cold-chain requirements and their intrinsic vulnerability to structural degradation. Dissolving microneedle (DMN) patches have recently been identified as a transdermal platform which allows minimally invasive, self-administered drug delivery and solid-state stabilization of fragile biologics. However, it is a significant challenge to keep the structural integrity and biological activity of proteins when developing the formulation, fabricating the microneedles, drying, storing the fabricates, and applying them to the skin. The mechanisms of molecular degradation (e.g., unfolding, aggregation, fibrillation, oxidation, deamidation, interface-induced denaturation) and stabilization (e.g., water replacement, vitrification, preferential hydration, and molecular confinement) all contribute to the stability of proteins in DMN matrices. Other processes also modulate these processes, such as polymer–protein interactions, residual moisture, glass-transition behavior, molecular mobility and microenvironmental physicochemical conditions. The rational engineering of polymer matrices, excipients systems and processing conditions therefore is the key to preserving a higher-order protein structure while providing sufficient mechanical properties, quick dissolution, higher drug loading efficiency and reproducible intradermal delivery. In recent years, a wide range of multifunctional biomaterials, hybrid polymer architectures, carrier-free insulin formulations and stimuli-responsive matrices have significantly broadened the design space for insulin and other biologic formulations that enables their stabilization during ambient and accelerated storage. Moreover, recent developments in biophysical characterization, solid-state analytical methods and computational modeling have helped to gain insight into formulation–structure–function relationships, and accelerated the rational optimization of protein-loaded DMN systems. Yet, there are still many difficulties to overcome for long-term stability, scalable manufacturing, quality-by-design implementation, regulatory standardization and global deployment. By combining mechanistic protein biophysics, pharmaceutical formulation and translational manufacturing, a platform for robust, cold-chain independent dissolving microneedles with a wide range of clinical applications across next-generation biologic therapeutics can be built.Keywords
Funding Information
- DST-INSPIRE Fellowship (IF220543)
This publication has 193 references indexed in Scilit:
- Nanoclay‐Engineered Scaffolds for the Controlled Delivery of Biomolecules in Regenerative MedicineAsia-Pacific Journal of Chemical Engineering, 2026
- Dissolving Microneedle for Maintaining the Integrity of HPV Virus‐Like Particles Enabling Durable Sterile Protection Across Various Mucosal TissuesAdvanced Healthcare Materials, 2025
- A Spatially Distributed Microneedle System for Bioorthogonal T Cell‐Guided Cancer TherapyAdvanced Science, 2025
- Pharmaceutical proteins at the interfaces and the role of albuminBiotechnology Progress, 2024
- Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical DevelopmentClinical Pharmacology & Therapeutics, 2024
- Self‐Assembly of Structured Colloidal Gels for High‐Resolution 3D Micropatterning of Proteins at ScaleAdvanced Materials, 2023
- Egg Microneedle for Transdermal Delivery of Active LiraglutideAdvanced Healthcare Materials, 2023
- Formulation of two‐layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic miceJournal of Biomedical Materials Research Part A, 2016
- Directed Self‐Assembly of Block Copolymers on Two‐Dimensional Chemical Patterns Fabricated by Electro‐Oxidation NanolithographyAdvanced Materials, 2010
- Trehalose and Protein StabilityCurrent Protocols in Protein Science, 2010